BSE Live
Jan 02, 13:50Prev. Close
73.59
Open Price
73.01
Bid Price (Qty.)
72.38 (25)
Offer Price (Qty.)
73.22 (172)
NSE Live
Jan 02, 13:50Prev. Close
73.02
Open Price
71.25
Bid Price (Qty.)
72.69 (1)
Offer Price (Qty.)
73.12 (1)
| Key Financial Ratios of Bal Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -6.28 | 4.77 | 4.19 | 3.50 | 2.18 | |
| Diluted EPS (Rs.) | -6.28 | 4.77 | 4.19 | 3.50 | 2.18 | |
| Cash EPS (Rs.) | -1.32 | 9.08 | 8.94 | 8.30 | 7.60 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 46.53 | 54.23 | 50.97 | 46.98 | 44.05 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 46.53 | 54.23 | 50.97 | 46.98 | 44.05 | |
| Dividend / Share(Rs.) | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Revenue from Operations/Share (Rs.) | 120.43 | 157.40 | 148.07 | 159.42 | 153.55 | |
| PBDIT/Share (Rs.) | 7.31 | 16.27 | 17.14 | 16.59 | 14.48 | |
| PBIT/Share (Rs.) | 2.36 | 11.95 | 12.39 | 12.03 | 9.06 | |
| PBT/Share (Rs.) | -6.40 | 3.11 | 5.97 | 6.06 | 4.03 | |
| Net Profit/Share (Rs.) | -6.28 | 4.77 | 4.19 | 3.75 | 2.18 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 6.07 | 10.33 | 11.57 | 10.40 | 9.42 | |
| PBIT Margin (%) | 1.95 | 7.59 | 8.36 | 7.54 | 5.89 | |
| PBT Margin (%) | -5.31 | 1.97 | 4.02 | 3.80 | 2.62 | |
| Net Profit Margin (%) | -5.21 | 3.03 | 2.82 | 2.35 | 1.41 | |
| Return on Networth / Equity (%) | -13.49 | 8.79 | 8.22 | 7.98 | 4.94 | |
| Return on Capital Employed (%) | 3.36 | 14.84 | 14.91 | 17.66 | 3.39 | |
| Return on Assets (%) | -3.71 | 2.62 | 2.36 | 2.42 | 1.45 | |
| Total Debt/Equity (X) | 1.42 | 1.26 | 1.16 | 1.05 | 1.16 | |
| Asset Turnover Ratio (%) | 71.31 | 86.74 | 83.57 | 103.24 | 102.23 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.23 | 1.31 | 1.36 | 1.23 | 1.12 | |
| Quick Ratio (X) | 0.75 | 0.82 | 0.86 | 0.78 | 0.75 | |
| Inventory Turnover Ratio (X) | 2.53 | 3.21 | 3.17 | 4.16 | 4.75 | |
| Dividend Payout Ratio (NP) (%) | -15.92 | 25.27 | 0.00 | 26.67 | 50.50 | |
| Dividend Payout Ratio (CP) (%) | -75.56 | 13.27 | 0.00 | 12.04 | 14.49 | |
| Earnings Retention Ratio (%) | 115.92 | 74.73 | 0.00 | 73.33 | 49.50 | |
| Cash Earnings Retention Ratio (%) | 175.56 | 86.73 | 0.00 | 87.96 | 85.51 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 136.93 | 192.64 | 189.35 | 190.45 | 191.64 | |
| EV/Net Operating Revenue (X) | 0.80 | 0.86 | 0.90 | 0.84 | 0.97 | |
| EV/EBITDA (X) | 13.21 | 8.36 | 7.79 | 8.10 | 10.28 | |
| MarketCap/Net Operating Revenue (X) | 0.27 | 0.45 | 0.52 | 0.55 | 0.66 | |
| Retention Ratios (%) | 115.92 | 74.72 | 0.00 | 73.32 | 49.49 | |
| Price/BV (X) | 0.70 | 1.30 | 1.51 | 1.88 | 2.29 | |
| Price/Net Operating Revenue | 0.27 | 0.45 | 0.52 | 0.55 | 0.66 | |
| Earnings Yield | -0.19 | 0.07 | 0.05 | 0.04 | 0.02 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y